Cambium Bio Ltd (CMB) — Capital Reinvestment Ratio

Latest as of December 2023: 0.02x

Cambium Bio Ltd (CMB) has a Capital Reinvestment Ratio of 0.02x as of December 2023, meaning it reinvests 0% of its operating cash flow (AU$148.25K) in capital expenditures (AU$2.27K). Check Cambium Bio Ltd (CMB) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.02x
Capex / Operating Cash Flow

Operating Cash Flow

AU$148.25K
AUD

Capital Expenditures

AU$2.27K
AUD

Data as of

Dec 2023
Most recent filing

Cambium Bio Ltd Capital Reinvestment Ratio (1999–2021)

This chart tracks Cambium Bio Ltd's Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Cambium Bio Ltd generate cash.

Annual Capital Reinvestment Ratio for Cambium Bio Ltd (1999–2021)

Year-by-year Capital Reinvestment Ratio for Cambium Bio Ltd from 1999 to 2021. See Cambium Bio Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2021 0.00x AU$2.42 Million AU$7.78K ▼ -92.3%
2017 0.04x AU$3.59 Million AU$149.95K ▼ -96.2%
2002 1.11x AU$5.43 Million AU$6.01 Million ▲ +107.3%
2001 0.53x AU$38.20 Million AU$20.40 Million ▲ +115.7%
2000 0.25x AU$48.26 Million AU$11.95 Million ▼ -54.9%
1999 0.55x AU$33.43 Million AU$18.35 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow